Last reviewed · How we verify

NCT04284072: SeizeIT2

Clinical Scenarios for Long-term Monitoring of Epileptic Seizures With a Wearable Biopotential Technology

Completed NA Last updated 8 November 2022
What this trial tests

NA trial testing Sensor Dot in Epilepsy in 496 participants. Completed in 30 June 2022.

Timeline
22 June 2020
Primary endpoint
30 June 2022
30 June 2022

Quick facts

Lead sponsorUniversitaire Ziekenhuizen KU Leuven
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsequential
Maskingnone
Primary purposediagnostic
Enrollment496
Start date22 June 2020
Primary completion30 June 2022
Estimated completion30 June 2022
Sites7 locations across Belgium, Sweden, United Kingdom, Germany, Portugal

Drugs / interventions tested

Conditions studied

Sponsor

Universitaire Ziekenhuizen KU Leuven — full company profile →

Who can join

4 and older, any sex, with Epilepsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinically validate a biopotential and motion recording wearable device (Byteflies Sensor Dot) for detection of epileptic seizures in the epilepsy monitoring unit (EMU) and at home.

Publications & conference data

7 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Accurate detection of typical absence seizures in adults and children using a two-channel electroencephalographic wearable behind the ears.
    Swinnen L, Chatzichristos C, Jansen K, Lagae L, et al · · 2021 · cited 57× · PMID 34490891 · DOI 10.1111/epi.17061
  2. The power of ECG in multimodal patient-specific seizure monitoring: Added value to an EEG-based detector using limited channels.
    Vandecasteele K, De Cooman T, Chatzichristos C, Cleeren E, et al · · 2021 · cited 38× · PMID 34240748 · DOI 10.1111/epi.16990
  3. High precision in epileptic seizure self-reporting with an app diary.
    Zabler N, Swinnen L, Biondi A, Novitskaya Y, et al · · 2024 · cited 10× · PMID 38982283 · DOI 10.1038/s41598-024-66932-y
  4. Classification with a Deferral Option and Low-Trust Filtering for Automated Seizure Detection.
    Becker T, Vandecasteele K, Chatzichristos C, Van Paesschen W, et al · · 2021 · cited 10× · PMID 33557034 · DOI 10.3390/s21041046
  5. SeizeIT2: Wearable Dataset Of Patients With Focal Epilepsy.
    Bhagubai M, Chatzichristos C, Swinnen L, Macea J, et al · · 2025 · cited 2× · PMID 40664714 · DOI 10.1038/s41597-025-05580-x
  6. Automated Sleep Staging in Epilepsy Using Deep Learning on Standard Electroencephalogram and Wearable Data.
    Macea J, Heremans ERM, Proost R, De Vos M, et al · · 2025 · cited 1× · PMID 40176726 · DOI 10.1111/jsr.70061
  7. A multicenter, video-EEG-based validation of a multimodal wearable device for focal seizure detection in adults: The SeizeIT2 study.
    Swinnen L, Bhagubai M, Chatzichristos C, Weber Y, et al · · 2026 · PMID 41949013 · DOI 10.1002/epi4.70260

Verify or expand the search:

Other recruiting trials for Epilepsy

Currently open trials in the same condition.

Other Universitaire Ziekenhuizen KU Leuven trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04284072.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing